{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T10:24:41Z","timestamp":1779099881334,"version":"3.51.4"},"reference-count":189,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82371446"],"award-info":[{"award-number":["82371446"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82371441"],"award-info":[{"award-number":["82371441"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Natural Science Foundation of Beijing Municipality","award":["IS23093"],"award-info":[{"award-number":["IS23093"]}]},{"name":"Natural Science Foundation of Beijing Municipality","award":["7254384"],"award-info":[{"award-number":["7254384"]}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"crossref","award":["STI2030-Major Projects 2022ZD0206800"],"award-info":[{"award-number":["STI2030-Major Projects 2022ZD0206800"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005090","name":"Beijing Nova Program","doi-asserted-by":"crossref","award":["20220484083"],"award-info":[{"award-number":["20220484083"]}],"id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s12035-025-04779-8","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T17:54:42Z","timestamp":1740506082000},"page":"8420-8438","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Role of Peripheral NLRP3 Inflammasome in Cognitive Impairments: Insights of Non-central Factors"],"prefix":"10.1007","volume":"62","author":[{"given":"Mengfan","family":"Qiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjun","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Qing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunjie","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenzhen","family":"Quan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"key":"4779_CR1","doi-asserted-by":"crossref","first-page":"701282","DOI":"10.3389\/fimmu.2021.701282","volume":"12","author":"H Bai","year":"2021","unstructured":"Bai H, Zhang Q (2021) Activation of NLRP3 inflammasome and onset of Alzheimer\u2019s disease. Front Immunol 12:701282","journal-title":"Front Immunol"},{"issue":"1","key":"4779_CR2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s12272-021-01307-9","volume":"44","author":"JK Seok","year":"2021","unstructured":"Seok JK, Kang HC, Cho YY, Lee HS, Lee JY (2021) Therapeutic regulation of the NLRP3 inflammasome in chronic inflammatory diseases. Arch Pharmacal Res 44(1):16\u201335","journal-title":"Arch Pharmacal Res"},{"issue":"12","key":"4779_CR3","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","volume":"25","author":"D Furman","year":"2019","unstructured":"Furman D, Campisi J, Verdin E, Carrera-Bastos P, Targ S, Franceschi C et al (2019) Chronic inflammation in the etiology of disease across the life span. Nat Med 25(12):1822\u20131832","journal-title":"Nat Med"},{"issue":"1","key":"4779_CR4","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s12035-018-1092-y","volume":"56","author":"G Morris","year":"2019","unstructured":"Morris G, Berk M, Maes M, Puri BK (2019) Could Alzheimer\u2019s disease originate in the periphery and if so how so? Mol Neurobiol 56(1):406\u2013434","journal-title":"Mol Neurobiol"},{"issue":"Pt A","key":"4779_CR5","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neuropharm.2014.06.020","volume":"96","author":"X Zheng","year":"2015","unstructured":"Zheng X, Zhang X, Kang A, Ran C, Wang G, Hao H (2015) Thinking outside the brain for cognitive improvement: is peripheral immunomodulation on the way? Neuropharmacology 96(Pt A):94\u2013104","journal-title":"Neuropharmacology"},{"issue":"2","key":"4779_CR6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/nn.4475","volume":"20","author":"M Prinz","year":"2017","unstructured":"Prinz M, Priller J (2017) The role of peripheral immune cells in the CNS in steady state and disease. Nat Neurosci 20(2):136\u2013144","journal-title":"Nat Neurosci"},{"issue":"6566","key":"4779_CR7","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1126\/science.abc6108","volume":"374","author":"S Carloni","year":"2021","unstructured":"Carloni S, Bertocchi A, Mancinelli S, Bellini M, Erreni M, Borreca A et al (2021) Identification of a choroid plexus vascular barrier closing during intestinal inflammation. Science (New York, NY) 374(6566):439\u2013448","journal-title":"Science (New York, NY)"},{"issue":"15\u201317","key":"4779_CR8","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1097\/00001756-199611040-00083","volume":"7","author":"RM Bluth\u00e9","year":"1996","unstructured":"Bluth\u00e9 RM, Michaud B, Kelley KW, Dantzer R (1996) Vagotomy blocks behavioural effects of interleukin-1 injected via the intraperitoneal route but not via other systemic routes. NeuroReport 7(15\u201317):2823\u20132827","journal-title":"NeuroReport"},{"issue":"7826","key":"4779_CR9","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41586-020-2425-3","volume":"585","author":"T Teratani","year":"2020","unstructured":"Teratani T, Mikami Y, Nakamoto N, Suzuki T, Harada Y, Okabayashi K et al (2020) The liver-brain-gut neural arc maintains the T(reg) cell niche in the gut. Nature 585(7826):591\u2013596","journal-title":"Nature"},{"issue":"4","key":"4779_CR10","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/s41579-020-00460-0","volume":"19","author":"LH Morais","year":"2021","unstructured":"Morais LH, Schreiber HLT, Mazmanian SK (2021) The gut microbiota-brain axis in behaviour and brain disorders. Nat Rev Microbiol 19(4):241\u2013255","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"4779_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-190848","volume":"75","author":"MF Bassendine","year":"2020","unstructured":"Bassendine MF, Taylor-Robinson SD, Fertleman M, Khan M, Neely D (2020) Is Alzheimer\u2019s disease a liver disease of the brain? J Alzheimer\u2019s Dis:JAD 75(1):1\u201314","journal-title":"J Alzheimer's Dis:JAD"},{"issue":"11","key":"4779_CR12","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.3390\/cells12111517","volume":"12","author":"J Fraile-Ramos","year":"2023","unstructured":"Fraile-Ramos J, Garrit A, Reig-Vilallonga J, Gim\u00e9nez-Llort L (2023) Hepatic oxi-inflammation and neophobia as potential liver-brain axis targets for Alzheimer\u2019s disease and aging, with strong sensitivity to sex, isolation, and obesity. Cells 12(11):1517","journal-title":"Cells"},{"issue":"4","key":"4779_CR13","first-page":"275","volume":"8","author":"Z Xie","year":"2022","unstructured":"Xie Z, Tong S, Chu X, Feng T, Geng M (2022) Chronic kidney disease and cognitive impairment: the kidney-brain axis. Kidney Dis (Basel, Switzerland) 8(4):275\u2013285","journal-title":"Kidney Dis (Basel, Switzerland)"},{"key":"4779_CR14","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.cortex.2022.06.002","volume":"154","author":"M Bertuccelli","year":"2022","unstructured":"Bertuccelli M, Ciringione L, Rubega M, Bisiacchi P, Masiero S, Del Felice A (2022) Cognitive impairment in people with previous COVID-19 infection: a scoping review. Cortex; J Devoted Study Nerv Syst Behav 154:212\u2013230","journal-title":"Cortex; J Devoted Study Nerv Syst Behav"},{"key":"4779_CR15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bbi.2021.12.020","volume":"101","author":"F Ceban","year":"2022","unstructured":"Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM et al (2022) Fatigue and cognitive impairment in post-COVID-19 syndrome: a systematic review and meta-analysis. Brain Behav Immun 101:93\u2013135","journal-title":"Brain Behav Immun"},{"issue":"5","key":"4779_CR16","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s10787-022-01038-3","volume":"30","author":"HM Al-Kuraishy","year":"2022","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Negm WA, Alexiou A, Batiha GE (2022) Ursolic acid and SARS-CoV-2 infection: a new horizon and perspective. Inflammopharmacology 30(5):1493\u20131501","journal-title":"Inflammopharmacology"},{"key":"4779_CR17","first-page":"e01407","volume":"18","author":"GE Batiha","year":"2022","unstructured":"Batiha GE, Al-Gareeb AI, Rotimi D, Adeyemi OS, Al-Kuraishy HM (2022) Common NLRP3 inflammasome inhibitors and Covid-19: divide and conquer. Sci Afr 18:e01407","journal-title":"Sci Afr"},{"issue":"8","key":"4779_CR18","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1007\/s00415-022-11077-z","volume":"269","author":"T Dondaine","year":"2022","unstructured":"Dondaine T, Ruthmann F, Vuotto F, Carton L, Gel\u00e9 P, Faure K et al (2022) Long-term cognitive impairments following COVID-19: a possible impact of hypoxia. J Neurol 269(8):3982\u20133989","journal-title":"J Neurol"},{"issue":"1","key":"4779_CR19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1017\/cjn.2020.173","volume":"48","author":"D Roy","year":"2021","unstructured":"Roy D, Ghosh R, Dubey S, Dubey MJ, Benito-Le\u00f3n J, Kanti RB (2021) Neurological and neuropsychiatric impacts of COVID-19 pandemic. Can J Neurol Sci Le Journal Canadien des Sciences Neurologiques 48(1):9\u201324","journal-title":"Can J Neurol Sci Le Journal Canadien des Sciences Neurologiques"},{"key":"4779_CR20","doi-asserted-by":"crossref","first-page":"770459","DOI":"10.3389\/fpsyg.2022.770459","volume":"13","author":"AM Henneghan","year":"2022","unstructured":"Henneghan AM, Lewis KA, Gill E, Kesler SR (2022) Cognitive impairment in non-critical, mild-to-moderate COVID-19 survivors. Front Psychol 13:770459","journal-title":"Front Psychol"},{"issue":"1","key":"4779_CR21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s11658-023-00462-9","volume":"28","author":"Y Chen","year":"2023","unstructured":"Chen Y, Ye X, Escames G, Lei W, Zhang X, Li M et al (2023) The NLRP3 inflammasome: contributions to inflammation-related diseases. Cell Mol Biol Lett 28(1):51","journal-title":"Cell Mol Biol Lett"},{"issue":"1","key":"4779_CR22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40035-023-00343-3","volume":"12","author":"C de Dios","year":"2023","unstructured":"de Dios C, Abadin X, Roca-Agujetas V, Jimenez-Martinez M, Morales A, Trullas R et al (2023) Inflammasome activation under high cholesterol load triggers a protective microglial phenotype while promoting neuronal pyroptosis. Transl Neurodegener 12(1):10","journal-title":"Transl Neurodegener"},{"issue":"7904","key":"4779_CR23","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41586-022-04467-w","volume":"604","author":"IV Hochheiser","year":"2022","unstructured":"Hochheiser IV, Pilsl M, Hagelueken G, Moecking J, Marleaux M, Brinkschulte R et al (2022) Structure of the NLRP3 decamer bound to the cytokine release inhibitor CRID3. Nature 604(7904):184\u2013189","journal-title":"Nature"},{"key":"4779_CR24","doi-asserted-by":"crossref","first-page":"1077222","DOI":"10.3389\/fphar.2022.1077222","volume":"13","author":"Z Yang","year":"2022","unstructured":"Yang Z, Liu J, Wei S, Deng J, Feng X, Liu S et al (2022) A novel strategy for bioactive natural products targeting NLRP3 inflammasome in Alzheimer\u2019s disease. Front Pharmacol 13:1077222","journal-title":"Front Pharmacol"},{"key":"4779_CR25","doi-asserted-by":"crossref","first-page":"676621","DOI":"10.3389\/fimmu.2021.676621","volume":"12","author":"AP Passaro","year":"2021","unstructured":"Passaro AP, Lebos AL, Yao Y, Stice SL (2021) Immune response in neurological pathology: emerging role of central and peripheral immune crosstalk. Front Immunol 12:676621","journal-title":"Front Immunol"},{"issue":"7434","key":"4779_CR26","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature11729","volume":"493","author":"MT Heneka","year":"2013","unstructured":"Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A et al (2013) NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice. Nature 493(7434):674\u2013678","journal-title":"Nature"},{"issue":"1","key":"4779_CR27","doi-asserted-by":"crossref","first-page":"5182","DOI":"10.1038\/s41467-018-07573-4","volume":"9","author":"I Hafner-Bratkovi\u010d","year":"2018","unstructured":"Hafner-Bratkovi\u010d I, Su\u0161jan P, Lain\u0161\u010dek D, Tapia-Abell\u00e1n A, Cerovi\u0107 K, Kadunc L et al (2018) NLRP3 lacking the leucine-rich repeat domain can be fully activated via the canonical inflammasome pathway. Nat Commun 9(1):5182","journal-title":"Nat Commun"},{"key":"4779_CR28","doi-asserted-by":"crossref","first-page":"805169","DOI":"10.3389\/fnmol.2022.805169","volume":"15","author":"J Hulse","year":"2022","unstructured":"Hulse J, Bhaskar K (2022) Crosstalk between the NLRP3 inflammasome\/ASC Speck and amyloid protein aggregates drives disease progression in Alzheimer\u2019s and Parkinson\u2019s disease. Front Mol Neurosci 15:805169","journal-title":"Front Mol Neurosci"},{"key":"4779_CR29","doi-asserted-by":"crossref","first-page":"110239","DOI":"10.1016\/j.intimp.2023.110239","volume":"119","author":"WW Ibrahim","year":"2023","unstructured":"Ibrahim WW, Skalicka-Wo\u017aniak K, Budzy\u0144ska B, El Sayed NS (2023) NLRP3 inflammasome inhibition and M1-to-M2 microglial polarization shifting via scoparone-inhibited TLR4 axis in ovariectomy\/D-galactose Alzheimer\u2019s disease rat model. Int Immunopharmacol 119:110239","journal-title":"Int Immunopharmacol"},{"issue":"16","key":"4779_CR30","doi-asserted-by":"crossref","first-page":"8979","DOI":"10.3390\/ijms23168979","volume":"23","author":"J Barczuk","year":"2022","unstructured":"Barczuk J, Siwecka N, Lusa W, Rozp\u0119dek-Kami\u0144ska W, Kucharska E, Majsterek I (2022) Targeting NLRP3-mediated neuroinflammation in Alzheimer\u2019s disease treatment. Int J Mol Sci 23(16):8979","journal-title":"Int J Mol Sci"},{"issue":"4","key":"4779_CR31","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3390\/biomedicines11040999","volume":"11","author":"A Chiarini","year":"2023","unstructured":"Chiarini A, Gui L, Viviani C, Armato U, Dal Pr\u00e0 I (2023) NLRP3 inflammasome\u2019s activation in acute and chronic brain diseases-an update on pathogenetic mechanisms and therapeutic perspectives with respect to other inflammasomes. Biomedicines 11(4):999","journal-title":"Biomedicines"},{"issue":"11","key":"4779_CR32","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1007\/s11064-020-03121-z","volume":"45","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Zhao Y, Zhang J, Yang G (2020) Mechanisms of NLRP3 inflammasome activation: its role in the treatment of Alzheimer\u2019s disease. Neurochem Res 45(11):2560\u20132572","journal-title":"Neurochem Res"},{"issue":"1","key":"4779_CR33","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12974-021-02329-2","volume":"18","author":"W Rui","year":"2021","unstructured":"Rui W, Xiao H, Fan Y, Ma Z, Xiao M, Li S et al (2021) Systemic inflammasome activation and pyroptosis associate with the progression of amnestic mild cognitive impairment and Alzheimer\u2019s disease. J Neuroinflammation 18(1):280","journal-title":"J Neuroinflammation"},{"issue":"4","key":"4779_CR34","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.immuni.2023.03.003","volume":"56","author":"F Zhu","year":"2023","unstructured":"Zhu F, Ma J, Li W, Liu Q, Qin X, Qian Y et al (2023) The orphan receptor Nur77 binds cytoplasmic LPS to activate the non-canonical NLRP3 inflammasome. Immunity 56(4):753-767.e758","journal-title":"Immunity"},{"issue":"8","key":"4779_CR35","doi-asserted-by":"crossref","first-page":"268","DOI":"10.31083\/j.rcm2308268","volume":"23","author":"YJ Jin","year":"2022","unstructured":"Jin YJ, An ZY, Sun ZX, Liu XC (2022) NLRP3 inflammasome as a therapeutic target for atherosclerosis: a focus on potassium outflow. Rev Cardiovasc Med 23(8):268","journal-title":"Rev Cardiovasc Med"},{"issue":"4","key":"4779_CR36","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.immuni.2016.01.012","volume":"44","author":"MM Gaidt","year":"2016","unstructured":"Gaidt MM, Ebert TS, Chauhan D, Schmidt T, Schmid-Burgk JL, Rapino F et al (2016) Human monocytes engage an alternative inflammasome pathway. Immunity 44(4):833\u2013846","journal-title":"Immunity"},{"key":"4779_CR37","doi-asserted-by":"crossref","first-page":"113683","DOI":"10.1016\/j.fct.2023.113683","volume":"174","author":"WJ Zhang","year":"2023","unstructured":"Zhang WJ, Li KY, Lan Y, Zeng HY, Chen SQ, Wang H (2023) NLRP3 inflammasome: a key contributor to the inflammation formation. Food Chem Toxicol: Int J Published Br Ind Biol Res Assoc 174:113683","journal-title":"Food Chem Toxicol: Int J Published Br Ind Biol Res Assoc"},{"issue":"12","key":"4779_CR38","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","volume":"41","author":"Y He","year":"2016","unstructured":"He Y, Hara H, N\u00fa\u00f1ez G (2016) Mechanism and regulation of NLRP3 inflammasome activation. Trends Biochem Sci 41(12):1012\u20131021","journal-title":"Trends Biochem Sci"},{"key":"4779_CR39","doi-asserted-by":"publisher","unstructured":"Kuriakose T, Man SM, Malireddi RK, Karki R, Kesavardhana S, Place DE et al (2016) ZBP1\/DAI is an innate sensor of influenza virus triggering the NLRP3 inflammasome and programmed cell death pathways. Sci Immunol 1(2). https:\/\/doi.org\/10.1126\/sciimmunol.aag2045","DOI":"10.1126\/sciimmunol.aag2045"},{"issue":"8","key":"4779_CR40","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","volume":"19","author":"KV Swanson","year":"2019","unstructured":"Swanson KV, Deng M, Ting JP (2019) The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol 19(8):477\u2013489","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"4779_CR41","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41590-019-0548-1","volume":"21","author":"S Zewinger","year":"2020","unstructured":"Zewinger S, Reiser J, Jankowski V, Alansary D, Hahm E, Triem S et al (2020) Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation. Nat Immunol 21(1):30\u201341","journal-title":"Nat Immunol"},{"issue":"4","key":"4779_CR42","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.tibs.2022.10.002","volume":"48","author":"J Xu","year":"2023","unstructured":"Xu J, N\u00fa\u00f1ez G (2023) The NLRP3 inflammasome: activation and regulation. Trends Biochem Sci 48(4):331\u2013344","journal-title":"Trends Biochem Sci"},{"issue":"5","key":"4779_CR43","doi-asserted-by":"crossref","first-page":"e110468","DOI":"10.15252\/embj.2021110468","volume":"42","author":"SA Hughes","year":"2023","unstructured":"Hughes SA, Lin M, Weir A, Huang B, Xiong L, Chua NK et al (2023) Caspase-8-driven apoptotic and pyroptotic crosstalk causes cell death and IL-1\u03b2 release in X-linked inhibitor of apoptosis (XIAP) deficiency. EMBO J 42(5):e110468","journal-title":"EMBO J"},{"issue":"6","key":"4779_CR44","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/jleuko\/qiad095","volume":"114","author":"C Yang","year":"2023","unstructured":"Yang C, Yuan R, Brauner C, Du Y, Ah Kioon MD, Barrat FJ et al (2023) Dichotomous roles of RIPK3 in regulating the IFN response and NLRP3 inflammasome in human monocytes. J Leukoc Biol 114(6):615\u2013629","journal-title":"J Leukoc Biol"},{"issue":"21","key":"4779_CR45","doi-asserted-by":"crossref","first-page":"8087","DOI":"10.3390\/ijms21218087","volume":"21","author":"M Cornut","year":"2020","unstructured":"Cornut M, Bourdonnay E, Henry T (2020) Transcriptional regulation of inflammasomes. Int J Mol Sci 21(21):8087","journal-title":"Int J Mol Sci"},{"key":"4779_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2023.07.029","volume":"530","author":"Y Li","year":"2023","unstructured":"Li Y, Changhong Y, Liyu Y, Changchang M, Zeng L, Yue L et al (2023) Transcription factor forkhead box P (Foxp) 1 reduces brain damage during cerebral ischemia-reperfusion injury in mice through FUN14 domain-containing protein 1. Neuroscience 530:1\u201316","journal-title":"Neuroscience"},{"key":"4779_CR47","doi-asserted-by":"crossref","first-page":"101907","DOI":"10.1016\/j.arr.2023.101907","volume":"87","author":"E Possemato","year":"2023","unstructured":"Possemato E, La Barbera L, Nobili A, Krashia P, D\u2019Amelio M (2023) The role of dopamine in NLRP3 inflammasome inhibition: implications for neurodegenerative diseases. Ageing Res Rev 87:101907","journal-title":"Ageing Res Rev"},{"issue":"1","key":"4779_CR48","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s10753-022-01730-0","volume":"46","author":"B Sharma","year":"2023","unstructured":"Sharma B, Satija G, Madan A, Garg M, Alam MM, Shaquiquzzaman M et al (2023) Role of NLRP3 inflammasome and its inhibitors as emerging therapeutic drug candidate for Alzheimer\u2019s disease: a review of mechanism of activation, regulation, and inhibition. Inflammation 46(1):56\u201387","journal-title":"Inflammation"},{"issue":"6","key":"4779_CR49","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.immuni.2013.05.016","volume":"38","author":"R Mu\u00f1oz-Planillo","year":"2013","unstructured":"Mu\u00f1oz-Planillo R, Kuffa P, Mart\u00ednez-Col\u00f3n G, Smith BL, Rajendiran TM, N\u00fa\u00f1ez G (2013) K\u207a efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity 38(6):1142\u20131153","journal-title":"Immunity"},{"issue":"7","key":"4779_CR50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0276-5","volume":"51","author":"M Xu","year":"2019","unstructured":"Xu M, Jiang Z, Wang C, Li N, Bo L, Zha Y et al (2019) Acetate attenuates inflammasome activation through GPR43-mediated Ca(2+)-dependent NLRP3 ubiquitination. Exp Mol Med 51(7):1\u201313","journal-title":"Exp Mol Med"},{"issue":"5","key":"4779_CR51","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/ni.2022","volume":"12","author":"H Wen","year":"2011","unstructured":"Wen H, Gris D, Lei Y, Jha S, Zhang L, Huang MT et al (2011) Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol 12(5):408\u2013415","journal-title":"Nat Immunol"},{"key":"4779_CR52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.metabol.2017.06.002","volume":"74","author":"J Rheinheimer","year":"2017","unstructured":"Rheinheimer J, de Souza BM, Cardoso NS, Bauer AC, Crispim D (2017) Current role of the NLRP3 inflammasome on obesity and insulin resistance: a systematic review. Metab: Clin Exp 74:1\u20139","journal-title":"Metab: Clin Exp"},{"issue":"2","key":"4779_CR53","doi-asserted-by":"crossref","first-page":"e13124","DOI":"10.1111\/sji.13124","volume":"95","author":"M Kinra","year":"2022","unstructured":"Kinra M, Nampoothiri M, Arora D, Mudgal J (2022) Reviewing the importance of TLR-NLRP3-pyroptosis pathway and mechanism of experimental NLRP3 inflammasome inhibitors. Scand J Immunol 95(2):e13124","journal-title":"Scand J Immunol"},{"key":"4779_CR54","doi-asserted-by":"crossref","first-page":"677738","DOI":"10.3389\/fphar.2022.677738","volume":"13","author":"C Liao","year":"2022","unstructured":"Liao C, Wang D, Qin S, Zhang Y, Chen J, Xu R et al (2022) Inflammatory-dependent bidirectional effect of bile acids on NLRP3 inflammasome and its role in ameliorating CPT-11-induced colitis. Front Pharmacol 13:677738","journal-title":"Front Pharmacol"},{"issue":"5","key":"4779_CR55","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s41590-021-00886-5","volume":"22","author":"BR Sharma","year":"2021","unstructured":"Sharma BR, Kanneganti TD (2021) NLRP3 inflammasome in cancer and metabolic diseases. Nat Immunol 22(5):550\u2013559","journal-title":"Nat Immunol"},{"issue":"1","key":"4779_CR56","first-page":"550","volume":"25","author":"PK Chen","year":"2024","unstructured":"Chen PK, Tang KT, Chen DY (2024) The NLRP3 inflammasome as a pathogenic player showing therapeutic potential in rheumatoid arthritis and its comorbidities: a narrative review. Int J Mol Sci 25(1):550\u2013559","journal-title":"Int J Mol Sci"},{"issue":"7","key":"4779_CR57","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.autrev.2018.01.020","volume":"17","author":"HH Shen","year":"2018","unstructured":"Shen HH, Yang YX, Meng X, Luo XY, Li XM, Shuai ZW et al (2018) NLRP3: a promising therapeutic target for autoimmune diseases. Autoimmun Rev 17(7):694\u2013702","journal-title":"Autoimmun Rev"},{"issue":"1","key":"4779_CR58","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12944-017-0595-2","volume":"16","author":"J Lee","year":"2017","unstructured":"Lee J, Wan J, Lee L, Peng C, Xie H, Lee C (2017) Study of the NLRP3 inflammasome component genes and downstream cytokines in patients with type 2 diabetes mellitus with carotid atherosclerosis. Lipids Health Dis 16(1):217","journal-title":"Lipids Health Dis"},{"key":"4779_CR59","doi-asserted-by":"crossref","first-page":"900254","DOI":"10.3389\/fimmu.2022.900254","volume":"13","author":"J Ye","year":"2022","unstructured":"Ye J, Li L, Wang M, Ma Q, Tian Y, Zhang Q et al (2022) Diabetes mellitus promotes the development of atherosclerosis: the role of NLRP3. Front Immunol 13:900254","journal-title":"Front Immunol"},{"issue":"1","key":"4779_CR60","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1128\/IAI.00862-13","volume":"82","author":"E Park","year":"2014","unstructured":"Park E, Na HS, Song YR, Shin SY, Kim YM, Chung J (2014) Activation of NLRP3 and AIM2 inflammasomes by Porphyromonas gingivalis infection. Infect Immun 82(1):112\u2013123","journal-title":"Infect Immun"},{"issue":"1","key":"4779_CR61","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12943-018-0900-3","volume":"17","author":"M Moossavi","year":"2018","unstructured":"Moossavi M, Parsamanesh N, Bahrami A, Atkin SL, Sahebkar A (2018) Role of the NLRP3 inflammasome in cancer. Mol Cancer 17(1):158","journal-title":"Mol Cancer"},{"issue":"1","key":"4779_CR62","doi-asserted-by":"crossref","first-page":"2167172","DOI":"10.1080\/19490976.2023.2167172","volume":"15","author":"J Jin","year":"2023","unstructured":"Jin J, Xu Z, Zhang L, Zhang C, Zhao X, Mao Y et al (2023) Gut-derived \u03b2-amyloid: likely a centerpiece of the gut-brain axis contributing to Alzheimer\u2019s pathogenesis. Gut microbes 15(1):2167172","journal-title":"Gut microbes"},{"issue":"18","key":"4779_CR63","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1016\/j.neuron.2023.06.002","volume":"111","author":"Y Wu","year":"2023","unstructured":"Wu Y, Dong JH, Dai YF, Zhu MZ, Wang MY, Zhang Y et al (2023) Hepatic soluble epoxide hydrolase activity regulates cerebral A\u03b2 metabolism and the pathogenesis of Alzheimer\u2019s disease in mice. Neuron 111(18):2847-2862.e2810","journal-title":"Neuron"},{"issue":"1","key":"4779_CR64","doi-asserted-by":"crossref","first-page":"2302310","DOI":"10.1080\/19490976.2024.2302310","volume":"16","author":"Y Chen","year":"2024","unstructured":"Chen Y, Li Y, Fan Y, Chen S, Chen L, Chen Y et al (2024) Gut microbiota-driven metabolic alterations reveal gut-brain communication in Alzheimer\u2019s disease model mice. Gut Microbes 16(1):2302310","journal-title":"Gut Microbes"},{"issue":"1","key":"4779_CR65","doi-asserted-by":"crossref","first-page":"2126272","DOI":"10.1080\/19490976.2022.2126272","volume":"14","author":"J Lu","year":"2022","unstructured":"Lu J, Zhang S, Huang Y, Qian J, Tan B, Qian X et al (2022) Periodontitis-related salivary microbiota aggravates Alzheimer\u2019s disease via gut-brain axis crosstalk. Gut Microbes 14(1):2126272","journal-title":"Gut Microbes"},{"key":"4779_CR66","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ebiom.2019.08.032","volume":"47","author":"R Nagpal","year":"2019","unstructured":"Nagpal R, Neth BJ, Wang S, Craft S, Yadav H (2019) Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer\u2019s disease markers in subjects with mild cognitive impairment. EBioMedicine 47:529\u2013542","journal-title":"EBioMedicine"},{"issue":"6571","key":"4779_CR67","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1126\/science.abi6087","volume":"374","author":"G Agirman","year":"2021","unstructured":"Agirman G, Yu KB, Hsiao EY (2021) Signaling inflammation across the gut-brain axis. Science (New York, NY) 374(6571):1087\u20131092","journal-title":"Science (New York, NY)"},{"issue":"2","key":"4779_CR68","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/19490976.2019.1638722","volume":"11","author":"A Parker","year":"2020","unstructured":"Parker A, Fonseca S, Carding SR (2020) Gut microbes and metabolites as modulators of blood-brain barrier integrity and brain health. Gut Microbes 11(2):135\u2013157","journal-title":"Gut Microbes"},{"key":"4779_CR69","doi-asserted-by":"crossref","first-page":"632312","DOI":"10.3389\/fnins.2021.632312","volume":"15","author":"L Tsan","year":"2021","unstructured":"Tsan L, D\u00e9carie-Spain L, Noble EE, Kanoski SE (2021) Western diet consumption during development: setting the stage for neurocognitive dysfunction. Front Neurosci 15:632312","journal-title":"Front Neurosci"},{"issue":"6","key":"4779_CR70","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1016\/j.clnu.2021.04.043","volume":"40","author":"AK Muth","year":"2021","unstructured":"Muth AK, Park SQ (2021) The impact of dietary macronutrient intake on cognitive function and the brain. Clin Nutr (Edinburgh, Scotland) 40(6):3999\u20134010","journal-title":"Clin Nutr (Edinburgh, Scotland)"},{"issue":"11","key":"4779_CR71","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1093\/jn\/131.11.2943","volume":"131","author":"H Yoshida","year":"2001","unstructured":"Yoshida H, Miura S, Kishikawa H, Hirokawa M, Nakamizo H, Nakatsumi RC et al (2001) Fatty acids enhance GRO\/CINC-1 and interleukin-6 production in rat intestinal epithelial cells. J Nutr 131(11):2943\u20132950","journal-title":"J Nutr"},{"issue":"4","key":"4779_CR72","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.immuni.2015.09.003","volume":"43","author":"JS Lee","year":"2015","unstructured":"Lee JS, Tato CM, Joyce-Shaikh B, Gulen MF, Cayatte C, Chen Y et al (2015) Interleukin-23-independent IL-17 production regulates intestinal epithelial permeability. Immunity 43(4):727\u2013738","journal-title":"Immunity"},{"issue":"1","key":"4779_CR73","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40168-019-0621-x","volume":"7","author":"V Las Heras","year":"2019","unstructured":"Las Heras V, Clooney AG, Ryan FJ, Cabrera-Rubio R, Casey PG, Hueston CM et al (2019) Short-term consumption of a high-fat diet increases host susceptibility to Listeria monocytogenes infection. Microbiome 7(1):7","journal-title":"Microbiome"},{"key":"4779_CR74","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1146\/annurev-food-052720-011032","volume":"13","author":"V Las Heras","year":"2022","unstructured":"Las Heras V, Melgar S, MacSharry J, Gahan CGM (2022) The influence of the western diet on microbiota and gastrointestinal immunity. Annu Rev Food Sci Technol 13:489\u2013512","journal-title":"Annu Rev Food Sci Technol"},{"key":"4779_CR75","doi-asserted-by":"crossref","first-page":"101397","DOI":"10.1016\/j.arr.2021.101397","volume":"70","author":"A Wi\u0119ckowska-Gacek","year":"2021","unstructured":"Wi\u0119ckowska-Gacek A, Mietelska-Porowska A, Wydrych M, Wojda U (2021) Western diet as a trigger of Alzheimer\u2019s disease: from metabolic syndrome and systemic inflammation to neuroinflammation and neurodegeneration. Ageing Res Rev 70:101397","journal-title":"Ageing Res Rev"},{"key":"4779_CR76","doi-asserted-by":"crossref","first-page":"654509","DOI":"10.3389\/fnagi.2021.654509","volume":"13","author":"A Wi\u0229ckowska-Gacek","year":"2021","unstructured":"Wi\u0229ckowska-Gacek A, Mietelska-Porowska A, Chutora\u0144ski D, Wydrych M, D\u0142ugosz J, Wojda U (2021) Western diet induces impairment of liver-brain axis accelerating neuroinflammation and amyloid pathology in Alzheimer\u2019s disease. Front Aging Neurosci 13:654509","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"4779_CR77","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12974-018-1059-y","volume":"15","author":"JC d'Avila","year":"2018","unstructured":"d\u2019Avila JC, Siqueira LD, Mazeraud A, Azevedo EP, Foguel D, Castro-Faria-Neto HC et al (2018) Age-related cognitive impairment is associated with long-term neuroinflammation and oxidative stress in a mouse model of episodic systemic inflammation. J Neuroinflammation 15(1):28","journal-title":"J Neuroinflammation"},{"issue":"11","key":"4779_CR78","doi-asserted-by":"crossref","first-page":"12900","DOI":"10.1096\/fj.201900491RR","volume":"33","author":"P Gim\u00e9nez-G\u00f3mez","year":"2019","unstructured":"Gim\u00e9nez-G\u00f3mez P, P\u00e9rez-Hern\u00e1ndez M, O\u2019Shea E, Caso JR, Mart\u00edn-Hernandez D, Cervera LA et al (2019) Changes in brain kynurenine levels via gut microbiota and gut-barrier disruption induced by chronic ethanol exposure in mice. FASEB J: Off Publ Fed Am Soc Exp Biol 33(11):12900\u201312914","journal-title":"FASEB J: Off Publ Fed Am Soc Exp Biol"},{"issue":"2","key":"4779_CR79","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/s41380-022-01841-y","volume":"28","author":"H Yao","year":"2023","unstructured":"Yao H, Zhang D, Yu H, Yuan H, Shen H, Lan X et al (2023) Gut microbiota regulates chronic ethanol exposure-induced depressive-like behavior through hippocampal NLRP3-mediated neuroinflammation. Mol Psychiatry 28(2):919\u2013930","journal-title":"Mol Psychiatry"},{"issue":"17","key":"4779_CR80","doi-asserted-by":"crossref","first-page":"21470","DOI":"10.18632\/aging.203487","volume":"13","author":"S Ruan","year":"2021","unstructured":"Ruan S, Zhai L, Wu S, Zhang C, Guan Q (2021) SCFAs promote intestinal double-negative T cells to regulate the inflammatory response mediated by NLRP3 inflammasome. Aging 13(17):21470\u201321482","journal-title":"Aging"},{"issue":"7","key":"4779_CR81","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/nn.4030","volume":"18","author":"D Erny","year":"2015","unstructured":"Erny D, de Angelis ALH, Jaitin D, Wieghofer P, Staszewski O, David E et al (2015) Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci 18(7):965\u2013977","journal-title":"Nat Neurosci"},{"issue":"6","key":"4779_CR82","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00418-003-0532-5","volume":"119","author":"F De Jonge","year":"2003","unstructured":"De Jonge F, Van Nassauw L, Adriaensen D, Van Meir F, Miller HR, Van Marck E et al (2003) Effect of intestinal inflammation on capsaicin-sensitive afferents in the ileum of Schistosoma mansoni-infected mice. Histochem Cell Biol 119(6):477\u2013484","journal-title":"Histochem Cell Biol"},{"issue":"2","key":"4779_CR83","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s40473-014-0010-5","volume":"1","author":"RH Howland","year":"2014","unstructured":"Howland RH (2014) Vagus nerve stimulation. Curr Behav Neurosci Rep 1(2):64\u201373","journal-title":"Curr Behav Neurosci Rep"},{"key":"4779_CR84","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3389\/fpsyt.2018.00044","volume":"9","author":"S Breit","year":"2018","unstructured":"Breit S, Kupferberg A, Rogler G, Hasler G (2018) Vagus nerve as modulator of the brain-gut axis in psychiatric and inflammatory disorders. Front Psych 9:44","journal-title":"Front Psych"},{"issue":"5","key":"4779_CR85","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1111\/brv.12750","volume":"96","author":"A Milligan Armstrong","year":"2021","unstructured":"Milligan Armstrong A, Porter T, Quek H, White A, Haynes J, Jackaman C et al (2021) Chronic stress and Alzheimer\u2019s disease: the interplay between the hypothalamic-pituitary-adrenal axis, genetics and microglia. Biol Rev Camb Philos Soc 96(5):2209\u20132228","journal-title":"Biol Rev Camb Philos Soc"},{"issue":"17","key":"4779_CR86","doi-asserted-by":"crossref","first-page":"e106320","DOI":"10.15252\/embj.2020106320","volume":"40","author":"C Chen","year":"2021","unstructured":"Chen C, Zhou Y, Wang H, Alam A, Kang SS, Ahn EH et al (2021) Gut inflammation triggers C\/EBP\u03b2\/\u03b4-secretase-dependent gut-to-brain propagation of A\u03b2 and Tau fibrils in Alzheimer\u2019s disease. EMBO J 40(17):e106320","journal-title":"EMBO J"},{"issue":"8","key":"4779_CR87","doi-asserted-by":"crossref","first-page":"7205","DOI":"10.3390\/ijms24087205","volume":"24","author":"M Chen","year":"2023","unstructured":"Chen M, Mor DE (2023) Gut-to-brain \u03b1-synuclein transmission in Parkinson\u2019s disease: evidence for prion-like mechanisms. Int J Mol Sci 24(8):7205","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4779_CR88","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1474-4422(03)00307-7","volume":"2","author":"RF Pfeiffer","year":"2003","unstructured":"Pfeiffer RF (2003) Gastrointestinal dysfunction in Parkinson\u2019s disease. Lancet Neurol 2(2):107\u2013116","journal-title":"Lancet Neurol"},{"issue":"9","key":"4779_CR89","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1136\/gutjnl-2011-300474","volume":"61","author":"NA Koloski","year":"2012","unstructured":"Koloski NA, Jones M, Kalantar J, Weltman M, Zaguirre J, Talley NJ (2012) The brain\u2013gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study. Gut 61(9):1284\u20131290","journal-title":"Gut"},{"issue":"38","key":"4779_CR90","doi-asserted-by":"crossref","first-page":"16050","DOI":"10.1073\/pnas.1102999108","volume":"108","author":"JA Bravo","year":"2011","unstructured":"Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG et al (2011) Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci USA 108(38):16050\u201316055","journal-title":"Proc Natl Acad Sci USA"},{"key":"4779_CR91","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.neuroscience.2013.02.055","volume":"240","author":"S Davari","year":"2013","unstructured":"Davari S, Talaei SA, Alaei H, Salami M (2013) Probiotics treatment improves diabetes-induced impairment of synaptic activity and cognitive function: behavioral and electrophysiological proofs for microbiome-gut-brain axis. Neuroscience 240:287\u2013296","journal-title":"Neuroscience"},{"issue":"7","key":"4779_CR92","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.cell.2013.11.024","volume":"155","author":"EY Hsiao","year":"2013","unstructured":"Hsiao EY, McBride SW, Hsien S, Sharon G, Hyde ER, McCue T et al (2013) Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 155(7):1451\u20131463","journal-title":"Cell"},{"issue":"12","key":"4779_CR93","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1212\/WNL.0000000000002498","volume":"86","author":"SW Seo","year":"2016","unstructured":"Seo SW, Gottesman RF, Clark JM, Hernaez R, Chang Y, Kim C et al (2016) Nonalcoholic fatty liver disease is associated with cognitive function in adults. Neurology 86(12):1136\u20131142","journal-title":"Neurology"},{"issue":"2","key":"4779_CR94","doi-asserted-by":"crossref","first-page":"149","DOI":"10.5009\/gnl.2012.6.2.149","volume":"6","author":"GC Farrell","year":"2012","unstructured":"Farrell GC, van Rooyen D, Gan L, Chitturi S (2012) NASH is an inflammatory disorder: pathogenic, prognostic and therapeutic implications. Gut Liver 6(2):149\u2013171","journal-title":"Gut Liver"},{"issue":"1","key":"4779_CR95","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1021\/acs.jmedchem.0c01307","volume":"64","author":"AG Schwaid","year":"2021","unstructured":"Schwaid AG, Spencer KB (2021) Strategies for targeting the NLRP3 inflammasome in the clinical and preclinical space. J Med Chem 64(1):101\u2013122","journal-title":"J Med Chem"},{"issue":"22","key":"4779_CR96","doi-asserted-by":"crossref","first-page":"12284","DOI":"10.1128\/JVI.01962-13","volume":"87","author":"S Shrivastava","year":"2013","unstructured":"Shrivastava S, Mukherjee A, Ray R, Ray RB (2013) Hepatitis C virus induces interleukin-1\u03b2 (IL-1\u03b2)\/IL-18 in circulatory and resident liver macrophages. J Virol 87(22):12284\u201312290","journal-title":"J Virol"},{"key":"4779_CR97","doi-asserted-by":"crossref","first-page":"1188829","DOI":"10.3389\/fphar.2023.1188829","volume":"14","author":"IJ de Deus","year":"2023","unstructured":"de Deus IJ, Martins-Silva AF, Fagundes MMA, Paula-Gomes S, Silva F, da Cruz LL et al (2023) Role of NLRP3 inflammasome and oxidative stress in hepatic insulin resistance and the ameliorative effect of phytochemical intervention. Front Pharmacol 14:1188829","journal-title":"Front Pharmacol"},{"issue":"7","key":"4779_CR98","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/oby.22821","volume":"28","author":"T Zheng","year":"2020","unstructured":"Zheng T, Wang Q, Dong Y, Ma W, Zhang Y, Zhao Y et al (2020) High glucose-aggravated hepatic insulin resistance: role of the NLRP3 inflammasome in Kupffer cells. Obesity (Silver Spring, Md) 28(7):1270\u20131282","journal-title":"Obesity (Silver Spring, Md)"},{"issue":"32","key":"4779_CR99","doi-asserted-by":"crossref","first-page":"43102","DOI":"10.1007\/s11356-021-14904-4","volume":"28","author":"A Sehgal","year":"2021","unstructured":"Sehgal A, Behl T, Kaur I, Singh S, Sharma N, Aleya L (2021) Targeting NLRP3 inflammasome as a chief instigator of obesity, contributing to local adipose tissue inflammation and insulin resistance. Environ Sci Pollut Res Int 28(32):43102\u201343113","journal-title":"Environ Sci Pollut Res Int"},{"issue":"13","key":"4779_CR100","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.scib.2023.06.003","volume":"68","author":"W Qin","year":"2023","unstructured":"Qin W, Weng J (2023) Hepatocyte NLRP3 interacts with PKC\u03b5 to drive hepatic insulin resistance and steatosis. Sci Bull 68(13):1413\u20131429","journal-title":"Sci Bull"},{"key":"4779_CR101","doi-asserted-by":"crossref","first-page":"1149239","DOI":"10.3389\/fendo.2023.1149239","volume":"14","author":"X Zhao","year":"2023","unstructured":"Zhao X, An X, Yang C, Sun W, Ji H, Lian F (2023) The crucial role and mechanism of insulin resistance in metabolic disease. Front Endocrinol 14:1149239","journal-title":"Front Endocrinol"},{"issue":"1","key":"4779_CR102","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s13098-023-01211-w","volume":"15","author":"H Zhang","year":"2023","unstructured":"Zhang H, Farooqui HFM, Zhu W, Niu T, Zhang Z, Zhang H (2023) Impact of insulin resistance on mild cognitive impairment in type 2 diabetes mellitus patients with non-alcoholic fatty liver disease. Diabetol Metab Syndr 15(1):229","journal-title":"Diabetol Metab Syndr"},{"key":"4779_CR103","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pneurobio.2013.06.004","volume":"108","author":"Z Chen","year":"2013","unstructured":"Chen Z, Zhong C (2013) Decoding Alzheimer\u2019s disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies. Prog Neurobiol 108:21\u201343","journal-title":"Prog Neurobiol"},{"issue":"13","key":"4779_CR104","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1111\/jcmm.17784","volume":"27","author":"M Alrouji","year":"2023","unstructured":"Alrouji M, Al-Kuraishy HM, Al-Gareeb AI, Alexiou A, Papadakis M, Jabir MS et al (2023) NF-\u03baB\/NLRP3 inflammasome axis and risk of Parkinson\u2019s disease in type 2 diabetes mellitus: a narrative review and new perspective. J Cell Mol Med 27(13):1775\u20131789","journal-title":"J Cell Mol Med"},{"issue":"12","key":"4779_CR105","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/j.euroneuro.2014.01.023","volume":"24","author":"M Brundel","year":"2014","unstructured":"Brundel M, Kappelle LJ, Biessels GJ (2014) Brain imaging in type 2 diabetes. Eur Neuropsychopharmacol: J Eur Coll Neuropsychopharmacol 24(12):1967\u20131981","journal-title":"Eur Neuropsychopharmacol: J Eur Coll Neuropsychopharmacol"},{"issue":"9","key":"4779_CR106","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.2337\/db11-1669","volume":"61","author":"G Musen","year":"2012","unstructured":"Musen G, Jacobson AM, Bolo NR, Simonson DC, Shenton ME, McCartney RL et al (2012) Resting-state brain functional connectivity is altered in type 2 diabetes. Diabetes 61(9):2375\u20132379","journal-title":"Diabetes"},{"issue":"1","key":"4779_CR107","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2337\/dc12-0493","volume":"36","author":"YD Reijmer","year":"2013","unstructured":"Reijmer YD, Brundel M, de Bresser J, Kappelle LJ, Leemans A, Biessels GJ (2013) Microstructural white matter abnormalities and cognitive functioning in type 2 diabetes: a diffusion tensor imaging study. Diabetes Care 36(1):137\u2013144","journal-title":"Diabetes Care"},{"key":"4779_CR108","doi-asserted-by":"publisher","unstructured":"Saltiel AR (2021) Insulin signaling in health and disease. J Clin Investig 131(1). https:\/\/doi.org\/10.1172\/JCI142241","DOI":"10.1172\/JCI142241"},{"key":"4779_CR109","doi-asserted-by":"crossref","first-page":"985109","DOI":"10.3389\/fnagi.2022.985109","volume":"14","author":"L Wang","year":"2022","unstructured":"Wang L, Sang B, Zheng Z (2022) Risk of dementia or cognitive impairment in non-alcoholic fatty liver disease: a systematic review and meta-analysis. Front Aging Neurosci 14:985109","journal-title":"Front Aging Neurosci"},{"issue":"12","key":"4779_CR110","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1210\/clinem\/dgad352","volume":"108","author":"Y Miao","year":"2023","unstructured":"Miao Y, Zhang B, Sun X, Ma X, Fang D, Zhang W et al (2023) The presence and severity of NAFLD are associated with cognitive impairment and hippocampal damage. J Clin Endocrinol Metab 108(12):3239\u20133249","journal-title":"J Clin Endocrinol Metab"},{"key":"4779_CR111","doi-asserted-by":"crossref","first-page":"109146","DOI":"10.1016\/j.jnutbio.2022.109146","volume":"110","author":"W Zhang","year":"2022","unstructured":"Zhang W, Wang J, Wang L, Shi R, Chu C, Shi Z et al (2022) Alternate-day fasting prevents non-alcoholic fatty liver disease and working memory impairment in diet-induced obese mice. J Nutr Biochem 110:109146","journal-title":"J Nutr Biochem"},{"issue":"6","key":"4779_CR112","first-page":"E517","volume":"244","author":"E Ferrannini","year":"1983","unstructured":"Ferrannini E, Wahren J, Faber OK, Felig P, Binder C, DeFronzo RA (1983) Splanchnic and renal metabolism of insulin in human subjects: a dose-response study. Am J Physiol 244(6):E517-527","journal-title":"Am J Physiol"},{"issue":"2 Pt 2","key":"4779_CR113","first-page":"R200","volume":"255","author":"AB Steffens","year":"1988","unstructured":"Steffens AB, Scheurink AJ, Porte D Jr, Woods SC (1988) Penetration of peripheral glucose and insulin into cerebrospinal fluid in rats. Am J Physiol 255(2 Pt 2):R200-204","journal-title":"Am J Physiol"},{"issue":"11","key":"4779_CR114","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1038\/s41593-019-0505-1","volume":"22","author":"HM Chow","year":"2019","unstructured":"Chow HM, Shi M, Cheng A, Gao Y, Chen G, Song X et al (2019) Age-related hyperinsulinemia leads to insulin resistance in neurons and cell-cycle-induced senescence. Nat Neurosci 22(11):1806\u20131819","journal-title":"Nat Neurosci"},{"issue":"3","key":"4779_CR115","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrneurol.2017.185","volume":"14","author":"SE Arnold","year":"2018","unstructured":"Arnold SE, Arvanitakis Z, Macauley-Rambach SL, Koenig AM, Wang HY, Ahima RS et al (2018) Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums. Nat Rev Neurol 14(3):168\u2013181","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"4779_CR116","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/01.wad.0000213866.86934.7e","volume":"20","author":"S Craft","year":"2006","unstructured":"Craft S (2006) Insulin resistance syndrome and Alzheimer disease: pathophysiologic mechanisms and therapeutic implications. Alzheimer Dis Assoc Disord 20(4):298\u2013301","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"4","key":"4779_CR117","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s11011-011-9261-y","volume":"26","author":"DA Ghareeb","year":"2011","unstructured":"Ghareeb DA, Hafez HS, Hussien HM, Kabapy NF (2011) Non-alcoholic fatty liver induces insulin resistance and metabolic disorders with development of brain damage and dysfunction. Metab Brain Dis 26(4):253\u2013267","journal-title":"Metab Brain Dis"},{"issue":"5","key":"4779_CR118","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.tins.2022.03.001","volume":"45","author":"W Chen","year":"2022","unstructured":"Chen W, Cai W, Hoover B, Kahn CR (2022) Insulin action in the brain: cell types, circuits, and diseases. Trends Neurosci 45(5):384\u2013400","journal-title":"Trends Neurosci"},{"issue":"14","key":"4779_CR119","doi-asserted-by":"crossref","first-page":"7621","DOI":"10.3390\/ijms25147621","volume":"25","author":"X Yang","year":"2024","unstructured":"Yang X, Qiu K, Jiang Y, Huang Y, Zhang Y, Liao Y (2024) Metabolic crosstalk between liver and brain: from diseases to mechanisms. Int J Mol Sci 25(14):7621","journal-title":"Int J Mol Sci"},{"issue":"6","key":"4779_CR120","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3390\/biology9060124","volume":"9","author":"J Warner","year":"2020","unstructured":"Warner J, Hardesty J, Zirnheld K, McClain C, Warner D, Kirpich I (2020) Soluble epoxide hydrolase inhibition in liver diseases: a review of current research and knowledge gaps. Biology 9(6):124","journal-title":"Biology"},{"key":"4779_CR121","doi-asserted-by":"crossref","first-page":"106570","DOI":"10.1016\/j.nbd.2024.106570","volume":"199","author":"DV Chandrashekar","year":"2024","unstructured":"Chandrashekar DV, Roules GC, Jagadeesan N, Panchal UR, Oyegbesan A, Imiruaye OE et al (2024) Hepatic LRP-1 plays an important role in amyloidosis in Alzheimer\u2019s disease mice: potential role in chronic heavy alcohol feeding. Neurobiol Dis 199:106570","journal-title":"Neurobiol Dis"},{"issue":"3","key":"4779_CR122","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.cardiores.2007.02.020","volume":"74","author":"V Llorente-Cort\u00e9s","year":"2007","unstructured":"Llorente-Cort\u00e9s V, Royo T, Otero-Vi\u00f1as M, Berrozpe M, Badimon L (2007) Sterol regulatory element binding proteins downregulate LDL receptor-related protein (LRP1) expression and LRP1-mediated aggregated LDL uptake by human macrophages. Cardiovasc Res 74(3):526\u2013536","journal-title":"Cardiovasc Res"},{"issue":"6","key":"4779_CR123","doi-asserted-by":"crossref","first-page":"e0041523","DOI":"10.1128\/jvi.00415-23","volume":"97","author":"E Berm\u00fadez-M\u00e9ndez","year":"2023","unstructured":"Berm\u00fadez-M\u00e9ndez E, Angelino P, van Keulen L, van de Water S, Rockx B, Pijlman GP et al (2023) Transcriptomic profiling reveals intense host-pathogen dispute compromising homeostasis during acute rift valley fever virus infection. J Virol 97(6):e0041523","journal-title":"J Virol"},{"issue":"6","key":"4779_CR124","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00401-023-02559-z","volume":"145","author":"Y Cheng","year":"2023","unstructured":"Cheng Y, He CY, Tian DY, Chen SH, Ren JR, Sun HL et al (2023) Physiological \u03b2-amyloid clearance by the liver and its therapeutic potential for Alzheimer\u2019s disease. Acta Neuropathol 145(6):717\u2013731","journal-title":"Acta Neuropathol"},{"key":"4779_CR125","first-page":"101417","volume":"33","author":"G Huang","year":"2023","unstructured":"Huang G, Zhang Y, Zhang Y, Ma Y (2023) Chronic kidney disease and NLRP3 inflammasome: pathogenesis, development and targeted therapeutic strategies. Biochem Biophys Rep 33:101417","journal-title":"Biochem Biophys Rep"},{"issue":"9","key":"4779_CR126","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/nep.12785","volume":"21","author":"HL Hutton","year":"2016","unstructured":"Hutton HL, Ooi JD, Holdsworth SR, Kitching AR (2016) The NLRP3 inflammasome in kidney disease and autoimmunity. Nephrology (Carlton) 21(9):736\u2013744","journal-title":"Nephrology (Carlton)"},{"issue":"1","key":"4779_CR127","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s41392-022-01036-5","volume":"7","author":"Q Yuan","year":"2022","unstructured":"Yuan Q, Tang B, Zhang C (2022) Signaling pathways of chronic kidney diseases, implications for therapeutics. Signal Transduct Target Ther 7(1):182","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"4779_CR128","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1532-5415.2009.02670.x","volume":"58","author":"K Yaffe","year":"2010","unstructured":"Yaffe K, Ackerson L, Kurella Tamura M, Le Blanc P, Kusek JW, Sehgal AR et al (2010) Chronic kidney disease and cognitive function in older adults: findings from the chronic renal insufficiency cohort cognitive study. J Am Geriatr Soc 58(2):338\u2013345","journal-title":"J Am Geriatr Soc"},{"key":"4779_CR129","doi-asserted-by":"crossref","first-page":"106626","DOI":"10.1016\/j.nbd.2024.106626","volume":"200","author":"Q Yan","year":"2024","unstructured":"Yan Q, Liu M, Xie Y, Lin Y, Fu P, Pu Y et al (2024) Kidney-brain axis in the pathogenesis of cognitive impairment. Neurobiol Dis 200:106626","journal-title":"Neurobiol Dis"},{"issue":"7","key":"4779_CR130","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1093\/ndt\/gfx240","volume":"33","author":"P Joshee","year":"2018","unstructured":"Joshee P, Wood AG, Wood ER, Grunfeld EA (2018) Meta-analysis of cognitive functioning in patients following kidney transplantation. Nephrol Dialysis Transplant: Off Publ Eur Dial Transplant Assoc-Eur Renal Assoc 33(7):1268\u20131277","journal-title":"Nephrol Dialysis Transplant: Off Publ Eur Dial Transplant Assoc-Eur Renal Assoc"},{"issue":"3","key":"4779_CR131","doi-asserted-by":"crossref","first-page":"e531","DOI":"10.1097\/TXD.0000000000000976","volume":"6","author":"MS van Sandwijk","year":"2020","unstructured":"van Sandwijk MS, Ten Berge IJM, Caan MWA, D\u00fcring M, van Gool WA, Majoie C et al (2020) Cognitive improvement after kidney transplantation is associated with structural and functional changes on MRI. Transplant Dir 6(3):e531","journal-title":"Transplant Dir"},{"key":"4779_CR132","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3389\/fcvm.2020.00096","volume":"7","author":"M Miglinas","year":"2020","unstructured":"Miglinas M, Cesniene U, Janusaite MM, Vinikovas A (2020) Cerebrovascular disease and cognition in chronic kidney disease patients. Front Cardiovasc Med 7:96","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"4779_CR133","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.kint.2024.06.028","volume":"106","author":"S Zimmermann","year":"2024","unstructured":"Zimmermann S, Mathew A, Bondareva O, Elwakiel A, Waldmann K, Jiang S et al (2024) Chronic kidney disease leads to microglial potassium efflux and inflammasome activation in the brain. Kidney Int 106(6):1101\u20131116","journal-title":"Kidney Int"},{"issue":"5","key":"4779_CR134","first-page":"4236","volume":"16","author":"CC Wu","year":"2024","unstructured":"Wu CC, Tian YC, Lu CL, Wu MJ, Lim PS, Chiu YW et al (2024) AST-120 improved uremic pruritus by lowering indoxyl sulfate and inflammatory cytokines in hemodialysis patients. Aging 16(5):4236\u20134249","journal-title":"Aging"},{"issue":"1","key":"4779_CR135","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41581-018-0078-3","volume":"15","author":"OM Kuro","year":"2019","unstructured":"Kuro OM (2019) The Klotho proteins in health and disease. Nat Rev Nephrol 15(1):27\u201344","journal-title":"Nat Rev Nephrol"},{"issue":"10","key":"4779_CR136","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1093\/ndt\/gfx376","volume":"33","author":"B Fernandez-Fernandez","year":"2018","unstructured":"Fernandez-Fernandez B, Izquierdo MC, Vali\u00f1o-Rivas L, Nastou D, Sanz AB, Ortiz A et al (2018) Albumin downregulates Klotho in tubular cells. Nephrol Dial Transplant: Off Publ Eur Dial Transplant Assoc-Eur Ren Assoc 33(10):1712\u20131722","journal-title":"Nephrol Dial Transplant: Off Publ Eur Dial Transplant Assoc-Eur Ren Assoc"},{"issue":"4","key":"4779_CR137","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/MNH.0000000000000232","volume":"25","author":"C Francis","year":"2016","unstructured":"Francis C, David V (2016) Inflammation regulates fibroblast growth factor 23 production. Curr Opin Nephrol Hypertens 25(4):325\u2013332","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"8","key":"4779_CR138","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41581-020-0266-9","volume":"16","author":"D Viggiano","year":"2020","unstructured":"Viggiano D, Wagner CA, Martino G, Nedergaard M, Zoccali C, Unwin R et al (2020) Mechanisms of cognitive dysfunction in CKD. Nat Rev Nephrol 16(8):452\u2013469","journal-title":"Nat Rev Nephrol"},{"issue":"13","key":"4779_CR139","doi-asserted-by":"crossref","first-page":"7362","DOI":"10.3390\/ijms23137362","volume":"23","author":"M Rroji","year":"2022","unstructured":"Rroji M, Figurek A, Viggiano D, Capasso G, Spasovski G (2022) Phosphate in the context of cognitive impairment and other neurological disorders occurrence in chronic kidney disease. Int J Mol Sci 23(13):7362","journal-title":"Int J Mol Sci"},{"issue":"6","key":"4779_CR140","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41390-018-0054-4","volume":"84","author":"KA Teramo","year":"2018","unstructured":"Teramo KA, Klemetti MM, Widness JA (2018) Robust increases in erythropoietin production by the hypoxic fetus is a response to protect the brain and other vital organs. Pediatr Res 84(6):807\u2013812","journal-title":"Pediatr Res"},{"issue":"1","key":"4779_CR141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2013.07.032","volume":"172","author":"Y Wang","year":"2013","unstructured":"Wang Y, Cooke MJ, Sachewsky N, Morshead CM, Shoichet MS (2013) Bioengineered sequential growth factor delivery stimulates brain tissue regeneration after stroke. J Control Release\u202f: Off J Control Release Soc 172(1):1\u201311","journal-title":"J Control Release : Off J Control Release Soc"},{"issue":"2","key":"4779_CR142","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3233\/JAD-220103","volume":"87","author":"MLS de Asteasu","year":"2022","unstructured":"de Asteasu MLS, Cuevas-Lara C, Garc\u00eda-Hermoso A, Ram\u00edrez-V\u00e9lez R, Mart\u00ednez-Velilla N, Zambom-Ferraresi F et al (2022) Effects of physical exercise on the incidence of delirium and cognitive function in acutely hospitalized older adults: a systematic review with meta-analysis. J Alzheimer\u2019s Dis: JAD 87(2):503\u2013517","journal-title":"J Alzheimer\u2019s Dis: JAD"},{"issue":"11","key":"4779_CR143","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/ejhf.412","volume":"17","author":"NA Bello","year":"2015","unstructured":"Bello NA, Lewis EF, Desai AS, Anand IS, Krum H, McMurray JJ et al (2015) Increased risk of stroke with darbepoetin alfa in anaemic heart failure patients with diabetes and chronic kidney disease. Eur J Heart Fail 17(11):1201\u20131207","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"4779_CR144","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/j.1525-1497.2006.00613.x","volume":"21","author":"SK Inouye","year":"2006","unstructured":"Inouye SK, Zhang Y, Han L, Leo-Summers L, Jones R, Marcantonio E (2006) Recoverable cognitive dysfunction at hospital admission in older persons during acute illness. J Gen Intern Med 21(12):1276\u20131281","journal-title":"J Gen Intern Med"},{"issue":"5","key":"4779_CR145","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1007\/s12035-023-03229-7","volume":"60","author":"W He","year":"2023","unstructured":"He W, Hu Z, Zhong Y, Wu C, Li J (2023) The potential of NLRP3 inflammasome as a therapeutic target in neurological diseases. Mol Neurobiol 60(5):2520\u20132538","journal-title":"Mol Neurobiol"},{"key":"4779_CR146","doi-asserted-by":"crossref","first-page":"110229","DOI":"10.1016\/j.intimp.2023.110229","volume":"119","author":"L Liu","year":"2023","unstructured":"Liu L, Feng L, Gao J, Hu J, Li A, Zhu Y et al (2023) Parthenolide targets NLRP3 to treat inflammasome-related diseases. Int Immunopharmacol 119:110229","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"4779_CR147","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.3390\/ijms22031324","volume":"22","author":"JH Lee","year":"2021","unstructured":"Lee JH, Kim HJ, Kim JU, Yook TH, Kim KH, Lee JY et al (2021) A novel treatment strategy by natural products in NLRP3 inflammasome-mediated neuroinflammation in Alzheimer\u2019s and Parkinson\u2019s disease. Int J Mol Sci 22(3):1324","journal-title":"Int J Mol Sci"},{"issue":"50","key":"4779_CR148","doi-asserted-by":"crossref","first-page":"32145","DOI":"10.1073\/pnas.2009680117","volume":"117","author":"N Lonnemann","year":"2020","unstructured":"Lonnemann N, Hosseini S, Marchetti C, Skouras DB, Stefanoni D, D\u2019Alessandro A et al (2020) The NLRP3 inflammasome inhibitor OLT1177 rescues cognitive impairment in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci USA 117(50):32145\u201332154","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"4779_CR149","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41589-019-0277-7","volume":"15","author":"RC Coll","year":"2019","unstructured":"Coll RC, Hill JR, Day CJ, Zamoshnikova A, Boucher D, Massey NL et al (2019) MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition. Nat Chem Biol 15(6):556\u2013559","journal-title":"Nat Chem Biol"},{"issue":"3","key":"4779_CR150","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","volume":"21","author":"RC Coll","year":"2015","unstructured":"Coll RC, Robertson AA, Chae JJ, Higgins SC, Mu\u00f1oz-Planillo R, Inserra MC et al (2015) A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat Med 21(3):248\u2013255","journal-title":"Nat Med"},{"key":"4779_CR151","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.bbi.2016.12.014","volume":"61","author":"C Dempsey","year":"2017","unstructured":"Dempsey C, Rubio Araiz A, Bryson KJ, Finucane O, Larkin C, Mills EL et al (2017) Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-\u03b2 and cognitive function in APP\/PS1 mice. Brain Behav Immun 61:306\u2013316","journal-title":"Brain Behav Immun"},{"key":"4779_CR152","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bbrc.2022.04.076","volume":"611","author":"Y Ren","year":"2022","unstructured":"Ren Y, Wang Q, Yang Z, Feng L, Zhang Y (2022) MCC950 ameliorates the dementia symptom at the early age of line M83 mouse and reduces hippocampal \u03b1-synuclein accumulation. Biochem Biophys Res Commun 611:23\u201330","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"4779_CR153","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12974-023-02759-0","volume":"20","author":"A Grotemeyer","year":"2023","unstructured":"Grotemeyer A, Fischer JF, Koprich JB, Brotchie JM, Blum R, Volkmann J et al (2023) Inflammasome inhibition protects dopaminergic neurons from \u03b1-synuclein pathology in a model of progressive Parkinson\u2019s disease. J Neuroinflammation 20(1):79","journal-title":"J Neuroinflammation"},{"issue":"12","key":"4779_CR154","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1021\/acsmedchemlett.6b00198","volume":"7","author":"M Salla","year":"2016","unstructured":"Salla M, Butler MS, Pelingon R, Kaeslin G, Croker DE, Reid JC et al (2016) Identification, synthesis, and biological evaluation of the major human metabolite of NLRP3 inflammasome inhibitor MCC950. ACS Med Chem Lett 7(12):1034\u20131038","journal-title":"ACS Med Chem Lett"},{"issue":"8","key":"4779_CR155","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/nrd.2018.97","volume":"17","author":"MSJ Mangan","year":"2018","unstructured":"Mangan MSJ, Olhava EJ, Roush WR, Seidel HM, Glick GD, Latz E (2018) Targeting the NLRP3 inflammasome in inflammatory diseases. Nat Rev Drug Discovery 17(8):588\u2013606","journal-title":"Nat Rev Drug Discovery"},{"issue":"7","key":"4779_CR156","doi-asserted-by":"crossref","first-page":"E1530","DOI":"10.1073\/pnas.1716095115","volume":"115","author":"C Marchetti","year":"2018","unstructured":"Marchetti C, Swartzwelter B, Gamboni F, Neff CP, Richter K, Azam T et al (2018) OLT1177, a \u03b2-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation. Proc Natl Acad Sci USA 115(7):E1530\u2013E1539","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"4779_CR157","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s13075-018-1664-2","volume":"20","author":"C Marchetti","year":"2018","unstructured":"Marchetti C, Swartzwelter B, Koenders MI, Azam T, Tengesdal IW, Powers N et al (2018) NLRP3 inflammasome inhibitor OLT1177 suppresses joint inflammation in murine models of acute arthritis. Arthritis Res Ther 20(1):169","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"4779_CR158","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/FJC.0000000000000931","volume":"77","author":"GF Wohlford","year":"2020","unstructured":"Wohlford GF, Van Tassell BW, Billingsley HE, Kadariya D, Canada JM, Carbone S et al (2020) Phase 1B, Randomized, double-blinded, dose escalation, single-center, repeat dose safety and pharmacodynamics study of the oral NLRP3 inhibitor dapansutrile in subjects with NYHA II-III systolic heart failure. J Cardiovasc Pharmacol 77(1):49\u201360","journal-title":"J Cardiovasc Pharmacol"},{"issue":"5","key":"4779_CR159","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1016\/S2665-9913(20)30065-5","volume":"2","author":"V Kl\u00fcck","year":"2020","unstructured":"Kl\u00fcck V, Jansen T, Janssen M, Comarniceanu A, Efd\u00e9 M, Tengesdal IW et al (2020) Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial. Lancet Rheumatol 2(5):e270\u2013e280","journal-title":"Lancet Rheumatol"},{"issue":"Suppl 6","key":"4779_CR160","doi-asserted-by":"crossref","first-page":"vi31","DOI":"10.1093\/rheumatology\/kez448","volume":"58","author":"M Kacar","year":"2019","unstructured":"Kacar M, Pathak S, Savic S (2019) Hereditary systemic autoinflammatory diseases and Schnitzler\u2019s syndrome. Rheumatology (Oxford, England) 58(Suppl 6):vi31\u2013vi43","journal-title":"Rheumatology (Oxford, England)"},{"issue":"1","key":"4779_CR161","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12974-019-1471-y","volume":"16","author":"R Kuwar","year":"2019","unstructured":"Kuwar R, Rolfe A, Di L, Xu H, He L, Jiang Y et al (2019) A novel small molecular NLRP3 inflammasome inhibitor alleviates neuroinflammatory response following traumatic brain injury. J Neuroinflammation 16(1):81","journal-title":"J Neuroinflammation"},{"issue":"4","key":"4779_CR162","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/FJC.0000000000000718","volume":"74","author":"C Marchetti","year":"2019","unstructured":"Marchetti C (2019) The NLRP3 inflammasome as a pharmacological target. J Cardiovasc Pharmacol 74(4):285\u2013296","journal-title":"J Cardiovasc Pharmacol"},{"issue":"3","key":"4779_CR163","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s12035-017-0467-9","volume":"55","author":"J Yin","year":"2018","unstructured":"Yin J, Zhao F, Chojnacki JE, Fulp J, Klein WL, Zhang S et al (2018) NLRP3 inflammasome inhibitor ameliorates amyloid pathology in a mouse model of Alzheimer\u2019s disease. Mol Neurobiol 55(3):1977\u20131987","journal-title":"Mol Neurobiol"},{"issue":"11","key":"4779_CR164","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1084\/jem.20171419","volume":"214","author":"H Jiang","year":"2017","unstructured":"Jiang H, He H, Chen Y, Huang W, Cheng J, Ye J et al (2017) Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders. J Exp Med 214(11):3219\u20133238","journal-title":"J Exp Med"},{"issue":"3","key":"4779_CR165","first-page":"722","volume":"12","author":"S Han","year":"2023","unstructured":"Han S, He Z, Hu X, Li X, Zheng K, Huang Y et al (2023) Inhibiting NLRP3 inflammasome activation by CY-09 helps to restore cerebral glucose metabolism in 3\u00d7Tg-AD mice. Antioxidants (Basel, Switzerland) 12(3):722","journal-title":"Antioxidants (Basel, Switzerland)"},{"issue":"1","key":"4779_CR166","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1038\/s41467-018-04947-6","volume":"9","author":"H He","year":"2018","unstructured":"He H, Jiang H, Chen Y, Ye J, Wang A, Wang C et al (2018) Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity. Nat Commun 9(1):2550","journal-title":"Nat Commun"},{"key":"4779_CR167","doi-asserted-by":"crossref","first-page":"557170","DOI":"10.3389\/fnins.2020.557170","volume":"14","author":"C Yan","year":"2020","unstructured":"Yan C, Yan H, Mao J, Liu Y, Xu L, Zhao H et al (2020) Neuroprotective effect of oridonin on traumatic brain injury via inhibiting NLRP3 inflammasome in experimental mice. Front Neurosci 14:557170","journal-title":"Front Neurosci"},{"issue":"7\u20138","key":"4779_CR168","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1089\/neu.2021.0466","volume":"39","author":"XJ Zhao","year":"2022","unstructured":"Zhao XJ, Zhu HY, Wang XL, Lu XW, Pan CL, Xu L et al (2022) Oridonin ameliorates traumatic brain injury-induced neurological damage by improving mitochondrial function and antioxidant capacity and suppressing neuroinflammation through the Nrf2 pathway. J Neurotrauma 39(7\u20138):530\u2013543","journal-title":"J Neurotrauma"},{"issue":"12","key":"4779_CR169","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1111\/jcmm.12124","volume":"17","author":"ZY Zhang","year":"2013","unstructured":"Zhang ZY, Daniels R, Schluesener HJ (2013) Oridonin ameliorates neuropathological changes and behavioural deficits in a mouse model of cerebral amyloidosis. J Cell Mol Med 17(12):1566\u20131576","journal-title":"J Cell Mol Med"},{"issue":"3","key":"4779_CR170","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/FJC.0000000000001509","volume":"83","author":"M Yu","year":"2024","unstructured":"Yu M, Zhu ZF, Yang F, Yuan YF, Liao SD, Liu ML et al (2024) Different anti-inflammatory drugs on high-sensitivity C-reactive protein in patients after percutaneous coronary intervention: a pilot randomized clinical trial. J Cardiovasc Pharmacol 83(3):234\u2013242","journal-title":"J Cardiovasc Pharmacol"},{"issue":"3","key":"4779_CR171","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/FJC.0000000000001523","volume":"83","author":"N Martinez Naya","year":"2024","unstructured":"Martinez Naya N, Toldo S, Abbate A (2024) Colchicine leads the charge in post-percutaneous coronary intervention anti-inflammatory defense. J Cardiovasc Pharmacol 83(3):231\u2013233","journal-title":"J Cardiovasc Pharmacol"},{"issue":"5","key":"4779_CR172","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/cns.13086","volume":"25","author":"X Jin","year":"2019","unstructured":"Jin X, Liu MY, Zhang DF, Zhong X, Du K, Qian P et al (2019) Baicalin mitigates cognitive impairment and protects neurons from microglia-mediated neuroinflammation via suppressing NLRP3 inflammasomes and TLR4\/NF-\u03baB signaling pathway. CNS Neurosci Ther 25(5):575\u2013590","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"4779_CR173","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12974-020-01948-5","volume":"17","author":"DC Shippy","year":"2020","unstructured":"Shippy DC, Wilhelm C, Viharkumar PA, Raife TJ, Ulland TK (2020) \u03b2-Hydroxybutyrate inhibits inflammasome activation to attenuate Alzheimer\u2019s disease pathology. J Neuroinflammation 17(1):280","journal-title":"J Neuroinflammation"},{"issue":"10","key":"4779_CR174","first-page":"3467","volume":"168","author":"C Braatz","year":"2024","unstructured":"Braatz C, Komes MP, Ravichandran KA, de Fragas MG, Griep A, Schwartz S et al (2024) NLRP3-directed antisense oligonucleotides reduce microglial immunoactivities in vitro. J Neurochem 168(10):3467\u20133481","journal-title":"J Neurochem"},{"key":"4779_CR175","doi-asserted-by":"crossref","first-page":"108595","DOI":"10.1016\/j.intimp.2022.108595","volume":"106","author":"S Bakhshi","year":"2022","unstructured":"Bakhshi S, Shamsi S (2022) MCC950 in the treatment of NLRP3-mediated inflammatory diseases: latest evidence and therapeutic outcomes. Int Immunopharmacol 106:108595","journal-title":"Int Immunopharmacol"},{"key":"4779_CR176","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.3389\/fimmu.2019.02578","volume":"10","author":"A S\u00e1nchez-Fern\u00e1ndez","year":"2019","unstructured":"S\u00e1nchez-Fern\u00e1ndez A, Skouras DB, Dinarello CA, L\u00f3pez-Vales R (2019) OLT1177 (Dapansutrile), a selective NLRP3 inflammasome inhibitor, ameliorates experimental autoimmune encephalomyelitis pathogenesis. Front Immunol 10:2578","journal-title":"Front Immunol"},{"key":"4779_CR177","doi-asserted-by":"crossref","first-page":"113889","DOI":"10.1016\/j.expneurol.2021.113889","volume":"347","author":"J Amo-Aparicio","year":"2022","unstructured":"Amo-Aparicio J, Garcia-Garcia J, Puigdomenech M, Francos-Quijorna I, Skouras DB, Dinarello CA et al (2022) Inhibition of the NLRP3 inflammasome by OLT1177 induces functional protection and myelin preservation after spinal cord injury. Exp Neurol 347:113889","journal-title":"Exp Neurol"},{"key":"4779_CR178","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ejmech.2019.03.046","volume":"171","author":"X Hu","year":"2019","unstructured":"Hu X, Bai Z, Qiao J, Li H, Xu S, Wang X et al (2019) Effective enmein-type mimics of clinical candidate HAO472: design, synthesis and biological evaluation. Eur J Med Chem 171:169\u2013179","journal-title":"Eur J Med Chem"},{"key":"4779_CR179","doi-asserted-by":"crossref","first-page":"588467","DOI":"10.3389\/fphar.2020.588467","volume":"11","author":"MB Majnooni","year":"2020","unstructured":"Majnooni MB, Fakhri S, Shokoohinia Y, Kiyani N, Stage K, Mohammadi P et al (2020) Phytochemicals: potential therapeutic interventions against coronavirus-associated lung injury. Front Pharmacol 11:588467","journal-title":"Front Pharmacol"},{"issue":"13","key":"4779_CR180","doi-asserted-by":"crossref","first-page":"9792","DOI":"10.1074\/jbc.M109.082305","volume":"285","author":"C Juliana","year":"2010","unstructured":"Juliana C, Fernandes-Alnemri T, Wu J, Datta P, Solorzano L, Yu JW et al (2010) Anti-inflammatory compounds parthenolide and Bay 11\u20137082 are direct inhibitors of the inflammasome. J Biol Chem 285(13):9792\u20139802","journal-title":"J Biol Chem"},{"issue":"2","key":"4779_CR181","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1248\/bpb.33.238","volume":"33","author":"G Xu","year":"2010","unstructured":"Xu G, Dou J, Zhang L, Guo Q, Zhou C (2010) Inhibitory effects of baicalein on the influenza virus in vivo is determined by baicalin in the serum. Biol Pharm Bull 33(2):238\u2013243","journal-title":"Biol Pharm Bull"},{"issue":"5","key":"4779_CR182","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1093\/jac\/dkt534","volume":"69","author":"MK Nayak","year":"2014","unstructured":"Nayak MK, Agrawal AS, Bose S, Naskar S, Bhowmick R, Chakrabarti S et al (2014) Antiviral activity of baicalin against influenza virus H1N1-pdm09 is due to modulation of NS1-mediated cellular innate immune responses. J Antimicrob Chemother 69(5):1298\u20131310","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"4779_CR183","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/j.celrep.2017.02.004","volume":"18","author":"EL Goldberg","year":"2017","unstructured":"Goldberg EL, Asher JL, Molony RD, Shaw AC, Zeiss CJ, Wang C et al (2017) \u03b2-Hydroxybutyrate deactivates neutrophil nLRP3 inflammasome to relieve gout flares. Cell Rep 18(9):2077\u20132087","journal-title":"Cell Rep"},{"issue":"8","key":"4779_CR184","doi-asserted-by":"crossref","first-page":"702","DOI":"10.5152\/tjg.2021.191062","volume":"32","author":"E \u015eahin","year":"2021","unstructured":"\u015eahin E, Bektur Aykanat NE, Kacar S, Bagci R, Sahinturk V (2021) \u03b2-Hydroxybutyrate, one of the three main ketone bodies, ameliorates acute pancreatitis in rats by suppressing the NLRP3 inflammasome pathway. Turk J Gastroenterol: Off J Turk Soc Gastroenterol 32(8):702\u2013711","journal-title":"Turk J Gastroenterol: Off J Turk Soc Gastroenterol"},{"issue":"3","key":"4779_CR185","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nm.3804","volume":"21","author":"YH Youm","year":"2015","unstructured":"Youm YH, Nguyen KY, Grant RW, Goldberg EL, Bodogai M, Kim D et al (2015) The ketone metabolite \u03b2-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat Med 21(3):263\u2013269","journal-title":"Nat Med"},{"key":"4779_CR186","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.coi.2020.10.011","volume":"68","author":"MT Milner","year":"2021","unstructured":"Milner MT, Maddugoda M, G\u00f6tz J, Burgener SS, Schroder K (2021) The NLRP3 inflammasome triggers sterile neuroinflammation and Alzheimer\u2019s disease. Curr Opin Immunol 68:116\u2013124","journal-title":"Curr Opin Immunol"},{"issue":"4","key":"4779_CR187","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1002\/med.21781","volume":"41","author":"C Pellegrini","year":"2021","unstructured":"Pellegrini C, Martelli A, Antonioli L, Fornai M, Blandizzi C, Calderone V (2021) NLRP3 inflammasome in cardiovascular diseases: pathophysiological and pharmacological implications. Med Res Rev 41(4):1890\u20131926","journal-title":"Med Res Rev"},{"key":"4779_CR188","doi-asserted-by":"crossref","first-page":"1018848","DOI":"10.3389\/fnagi.2022.1018848","volume":"14","author":"R Lu","year":"2022","unstructured":"Lu R, Zhang L, Yang X (2022) Interaction between autophagy and the NLRP3 inflammasome in Alzheimer\u2019s and Parkinson\u2019s disease. Front Aging Neurosci 14:1018848","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"4779_CR189","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10571-021-01184-2","volume":"43","author":"C Panda","year":"2023","unstructured":"Panda C, Mahapatra RK (2023) Bi-directional relationship between autophagy and inflammasomes in neurodegenerative disorders. Cell Mol Neurobiol 43(1):115\u2013137","journal-title":"Cell Mol Neurobiol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04779-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-04779-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04779-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T15:02:52Z","timestamp":1751382172000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-04779-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":189,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["4779"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-04779-8","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,25]]},"assertion":[{"value":"13 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}